Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print August 12, 2010, DOI:10.2164/jandrol.110.010751

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
32/1/111    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amory, J. K.
Right arrow Articles by Griswold, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amory, J. K.
Right arrow Articles by Griswold, M. D.

Suppression of Spermatogenesis by Bisdichloroacetyldiamines Is Mediated by Inhibition of Testicular Retinoic Acid Biosynthesis

John K. Amory *, Charles H. Muller , Jakob A Shimshoni , Nina Isoherranen , Jisun Paik , Jan S Moreb , David W Amory , Ryan Evanoff , Alex S Goldstein , and Michael D. Griswold

* To whom correspondence should be addressed. E-mail: jamory{at}u.washington.edu.

Purpose: The bisdichloroacetyldiamine WIN 18,446 reversibly inhibits spermatogenesis in many species including humans; however, the mechanism by which WIN 18,446 functions is unknown. As retinoic acid is essential for spermatogenesis, we hypothesized that WIN 18,446 might inhibit retinoic acid biosynthesis from retinol (vitamin A) within the testes by inhibiting the enzyme aldehyde dehydrogenase 1a2 (ALDH1a2). Methods: We studied the effect of WIN 18,446 on ALDH1a2 enzyme activity in vitro, and in vivo on spermatogenesis and fertility in mature male rabbits for 16 weeks. Results: WIN 18,446 markedly inhibited ALDH1a2 enzyme activity in vitro with an IC50 of 0.3 µM. In vivo, the oral administration of 200 mg/kg WIN18,446 to male rabbits for sixteen weeks significantly reduced intra-testicular concentrations of retinoic acid, severely impaired spermatogenesis and caused infertility. Reduced concentrations of intra-testicular retinoic acid were apparent after only four weeks of treatment and preceded the decrease in sperm counts and the loss of mature germ cells in tissue samples. Sperm counts and fertility recovered after treatment was discontinued. Conclusions: These findings demonstrate that bisdichloroacetyldiamines such as WIN 18,446 reversibly suppress spermatogenesis via inhibition of testicular retinoic acid biosynthesis by ALDH1a2. These findings suggest that ALDH1a2 is a promising target for the development of a reversible, non-hormonal male contraceptive.


Key words: Contraception • Fertility • Sperm • Spermatogenesis • Testis




This article has been cited by other articles:


Home page
 EndocrinologyHome page
A. Gely-Pernot, M. Raverdeau, C. Celebi, C. Dennefeld, B. Feret, M. Klopfenstein, S. Yoshida, N. B. Ghyselinck, and M. Mark
Spermatogonia Differentiation Requires Retinoic Acid Receptor {gamma}
Endocrinology, January 1, 2012; 153(1): 438 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Y. Cheng and D. D. Mruk
The Blood-Testis Barrier and Its Implications for Male Contraception
Pharmacol. Rev., January 1, 2012; 64(1): 16 - 64.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2010 by The American Society of Andrology.